90: Human Papillomaviruses (IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans)

0 avg rating
( 0 ratings by Goodreads )
 
9789283212904: 90: Human Papillomaviruses (IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans)

This ninetieth volume of the IARC Monographs on the Evaluation of Carcinogenic Risks to Humans considers human papillomaviruses (HPVs) which were evaluated by a previous Working Group (IARC, 1995). The monograph in the present volume incorporates new data that have become available during the past decade.

HPVs represent the most common infectious agents that are transmitted sexually throughout the world; the major risk factors are behaviors associated with sexual activity. Although most infections are asymptomatic and are cleared within a period of 2 years, genital HPV infection can lead to clinical disease, including anogenital warts, cervical neoplasia, cervical cancer and other anogenital cancers. The risk for persistence of infection and progression of the more than 40 genital HPV types to grade 3 cervical intraepithelial neoplasia (CIN3) and cancer differs widely. Persistent infection with carcinogenic HPVs occurs in virtually all cases of cervical cancer.

Previous evaluations of HPVs have classified types 16 and 18 as carcinogenic to humans (group 1), types 31 and 33 as probably carcinogenic to humans (Group 2A) and some types other than 16, 18, 31 and 33 as possibly carcinogenic to humans (Group 2B). At that time, the evaluation of types 16 and 18 was based on the strong association between infection with these HPVs and cervical cancer. For types 31 and 33, the association was less strong.

The new epidemiological data reviewed in the present volume strongly support and further confirm the previous evaluation of types 16 and 18, and provide new evidence for other HPVs. This information, which includes strong evidence of carcinogenicity at sites other than the cervix, supports new evaluations for several other HPV types in addition to those mentioned above. Since the Working Group was convened in 2005, important innovations in HPV prophylaxis have occurred and these needed to be included in this volume. To date two prophylactic vaccines have been developed and used in large multicentric trials. This prophylactic vaccination is expected to reduce the incidence of HPV-related genital diseases. However, the benefits of prophylactic vaccines in a broad public health perspective will be achieved only if such vaccines can be provided to those groups of women for whom access to cervical cancer screening services is most problematic. Therefore, the development of second-generation vaccines that are expected to be cheaper, easier to deliver and to provide T-cell response against pre-existing HPV infections is highly desirable.

"synopsis" may belong to another edition of this title.

About the Author:

The International Agency for Research on Cancer (IARC) is part of the World Health Organization. IARC's mission is to coordinate and conduct research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer control. The Agency is involved in both epidemiological and laboratory research and disseminates scientific information through publications, meetings, courses, and fellowships.

"About this title" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

1.

The International Agency for Research on Cancer
Published by STATIONERY OFFICE BOOKS
ISBN 10: 9283212908 ISBN 13: 9789283212904
New Softcover Quantity Available: 1
Seller:
Kennys Bookstore
(Olney, MD, U.S.A.)
Rating
[?]

Book Description STATIONERY OFFICE BOOKS. Book Condition: New. 2007. 1st Edition. Paperback. Dimension: 240 x 171 x 37. Weight in Grams: 1136. . . . . . Books ship from the US and Ireland. Bookseller Inventory # V9789283212904

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 12.73
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

2.

The International Agency for Research on Cancer
Published by STATIONERY OFFICE BOOKS (2007)
ISBN 10: 9283212908 ISBN 13: 9789283212904
New Softcover First Edition Quantity Available: 1
Rating
[?]

Book Description STATIONERY OFFICE BOOKS, 2007. Book Condition: New. 2007. 1st Edition. Paperback. Dimension: 240 x 171 x 37. Weight in Grams: 1136. . . . . . . Bookseller Inventory # V9789283212904

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 12.76
Convert Currency

Add to Basket

Shipping: FREE
From Ireland to U.S.A.
Destination, Rates & Speeds

3.

World Health Organization
ISBN 10: 9283212908 ISBN 13: 9789283212904
New Paperback Quantity Available: 1
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Paperback. Book Condition: New. Not Signed; book. Bookseller Inventory # ria9789283212904_rkm

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 11.50
Convert Currency

Add to Basket

Shipping: US$ 5.18
From United Kingdom to U.S.A.
Destination, Rates & Speeds

4.

International Agency for Research on Cancer
Published by World Health Organization (2007)
ISBN 10: 9283212908 ISBN 13: 9789283212904
New Paperback Quantity Available: 1
Seller:
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description World Health Organization, 2007. Paperback. Book Condition: Brand New. 1st edition. 670 pages. 9.25x6.75x1.50 inches. In Stock. Bookseller Inventory # __9283212908

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 10.15
Convert Currency

Add to Basket

Shipping: US$ 8.03
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

The International Agency for Research on Cancer
Published by World Health Organization (2007)
ISBN 10: 9283212908 ISBN 13: 9789283212904
New Paperback First Edition Quantity Available: 1
Seller:
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description World Health Organization, 2007. Paperback. Book Condition: New. book. Bookseller Inventory # M9283212908

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 31.20
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

6.

The International Agency for Research on Cancer
Published by World Health Organization, Switzerland (2007)
ISBN 10: 9283212908 ISBN 13: 9789283212904
New Paperback Quantity Available: 1
Seller:
The Book Depository US
(London, United Kingdom)
Rating
[?]

Book Description World Health Organization, Switzerland, 2007. Paperback. Book Condition: New. Language: English . Brand New Book. This ninetieth volume of the IARC Monographs on the Evaluation of Carcinogenic Risks to Humans considers human papillomaviruses (HPVs) which were evaluated by a previous Working Group (IARC, 1995). The monograph in the present volume incorporates new data that have become available during the past decade. HPVs represent the most common infectious agents that are transmitted sexually throughout the world; the major risk factors are behaviors associated with sexual activity. Although most infections are asymptomatic and are cleared within a period of 2 years, genital HPV infection can lead to clinical disease, including anogenital warts, cervical neoplasia, cervical cancer and other anogenital cancers. The risk for persistence of infection and progression of the more than 40 genital HPV types to grade 3 cervical intraepithelial neoplasia (CIN3) and cancer differs widely. Persistent infection with carcinogenic HPVs occurs in virtually all cases of cervical cancer. Previous evaluations of HPVs have classified types 16 and 18 as carcinogenic to humans (group 1), types 31 and 33 as probably carcinogenic to humans (Group 2A) and some types other than 16, 18, 31 and 33 as possibly carcinogenic to humans (Group 2B). At that time, the evaluation of types 16 and 18 was based on the strong association between infection with these HPVs and cervical cancer. For types 31 and 33, the association was less strong. The new epidemiological data reviewed in the present volume strongly support and further confirm the previous evaluation of types 16 and 18, and provide new evidence for other HPVs. This information, which includes strong evidence of carcinogenicity at sites other than the cervix, supports new evaluations for several other HPV types in addition to those mentioned above. Since the Working Group was convened in 2005, important innovations in HPV prophylaxis have occurred and these needed to be included in this volume. To date two prophylactic vaccines have been developed and used in large multicentric trials. This prophylactic vaccination is expected to reduce the incidence of HPV-related genital diseases. However, the benefits of prophylactic vaccines in a broad public health perspective will be achieved only if such vaccines can be provided to those groups of women for whom access to cervical cancer screening services is most problematic. Therefore, the development of second-generation vaccines that are expected to be cheaper, easier to deliver and to provide T-cell response against pre-existing HPV infections is highly desirable. Bookseller Inventory # AAZ9789283212904

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 31.61
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

7.

The International Agency for Research on Cancer
Published by World Health Organization, Switzerland (2007)
ISBN 10: 9283212908 ISBN 13: 9789283212904
New Paperback Quantity Available: 1
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description World Health Organization, Switzerland, 2007. Paperback. Book Condition: New. Language: English . Brand New Book. This ninetieth volume of the IARC Monographs on the Evaluation of Carcinogenic Risks to Humans considers human papillomaviruses (HPVs) which were evaluated by a previous Working Group (IARC, 1995). The monograph in the present volume incorporates new data that have become available during the past decade. HPVs represent the most common infectious agents that are transmitted sexually throughout the world; the major risk factors are behaviors associated with sexual activity. Although most infections are asymptomatic and are cleared within a period of 2 years, genital HPV infection can lead to clinical disease, including anogenital warts, cervical neoplasia, cervical cancer and other anogenital cancers. The risk for persistence of infection and progression of the more than 40 genital HPV types to grade 3 cervical intraepithelial neoplasia (CIN3) and cancer differs widely. Persistent infection with carcinogenic HPVs occurs in virtually all cases of cervical cancer. Previous evaluations of HPVs have classified types 16 and 18 as carcinogenic to humans (group 1), types 31 and 33 as probably carcinogenic to humans (Group 2A) and some types other than 16, 18, 31 and 33 as possibly carcinogenic to humans (Group 2B). At that time, the evaluation of types 16 and 18 was based on the strong association between infection with these HPVs and cervical cancer. For types 31 and 33, the association was less strong. The new epidemiological data reviewed in the present volume strongly support and further confirm the previous evaluation of types 16 and 18, and provide new evidence for other HPVs. This information, which includes strong evidence of carcinogenicity at sites other than the cervix, supports new evaluations for several other HPV types in addition to those mentioned above. Since the Working Group was convened in 2005, important innovations in HPV prophylaxis have occurred and these needed to be included in this volume. To date two prophylactic vaccines have been developed and used in large multicentric trials. This prophylactic vaccination is expected to reduce the incidence of HPV-related genital diseases. However, the benefits of prophylactic vaccines in a broad public health perspective will be achieved only if such vaccines can be provided to those groups of women for whom access to cervical cancer screening services is most problematic. Therefore, the development of second-generation vaccines that are expected to be cheaper, easier to deliver and to provide T-cell response against pre-existing HPV infections is highly desirable. Bookseller Inventory # AAZ9789283212904

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 32.57
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

8.

IARC Working Group on the Evaluation of the Carcinogenic Risk of Chemicals to Humans
Published by IARC
ISBN 10: 9283212908 ISBN 13: 9789283212904
New Paperback Quantity Available: 5
Seller:
THE SAINT BOOKSTORE
(Southport, United Kingdom)
Rating
[?]

Book Description IARC. Paperback. Book Condition: New. New copy - Usually dispatched within 2 working days. Bookseller Inventory # B9789283212904

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 23.49
Convert Currency

Add to Basket

Shipping: US$ 9.29
From United Kingdom to U.S.A.
Destination, Rates & Speeds

9.

World Health Organization
Published by World Health Organization (2006)
ISBN 10: 9283212908 ISBN 13: 9789283212904
New Quantity Available: 1
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description World Health Organization, 2006. PAP. Book Condition: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Bookseller Inventory # GB-9789283212904

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 22.38
Convert Currency

Add to Basket

Shipping: US$ 12.05
From United Kingdom to U.S.A.
Destination, Rates & Speeds

10.

International Agency for Research on Cancer
Published by World Health Organization (2007)
ISBN 10: 9283212908 ISBN 13: 9789283212904
New Paperback Quantity Available: 1
Seller:
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description World Health Organization, 2007. Paperback. Book Condition: Brand New. 1st edition. 670 pages. 9.25x6.75x1.50 inches. In Stock. Bookseller Inventory # 9283212908

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 37.91
Convert Currency

Add to Basket

Shipping: US$ 8.03
From United Kingdom to U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book